Insider · CIK 0001452204

Bavier Paul S

Reports to the SEC for 2 companies · DANBURY, CT

sec.gov

Transactions

Companies

Filings

CIK

0001452204

Forms 4 and 5

Insider transactions

42 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2019-11-21	AVEDRO INCEmployee Stock Option (right to buy)D Disposition to Issuer	General Counsel and Sec.	DDisposition to Issuer	−4,719 sh	—	—	0
2019-11-21	AVEDRO INCRestricted Stock UnitsD Disposition to Issuer	General Counsel and Sec.	DDisposition to Issuer	−12.7K sh	—	—	0
2019-11-21	AVEDRO INCEmployee Stock Option (right to buy)D Disposition to Issuer	General Counsel and Sec.	DDisposition to Issuer	−8,988 sh	—	—	0
2019-11-21	AVEDRO INCD Disposition to Issuer	General Counsel and Sec.	DDisposition to Issuer	−606 sh	—	—	0
2019-11-21	AVEDRO INCEmployee Stock Option (right to buy)D Disposition to Issuer	General Counsel and Sec.	DDisposition to Issuer	−44.5K sh	—	—	0
2019-11-21	AVEDRO INCEmployee Stock Option (right to buy)D Disposition to Issuer	General Counsel and Sec.	DDisposition to Issuer	−84.5K sh	—	—	0
2019-11-21	AVEDRO INCEmployee Stock Option (right to buy)D Disposition to Issuer	General Counsel and Sec.	DDisposition to Issuer	−5,452 sh	—	—	0
2019-09-03	AVEDRO INCM Exercise/Conversion	General Counsel and Sec.	MExercise/Conversion	+848 sh	—	—	848
2019-09-03	AVEDRO INCRestricted Stock UnitsM Exercise/Conversion	General Counsel and Sec.	MExercise/Conversion	−848 sh	—	—	12,717
2019-09-03	AVEDRO INCF Tax Payment	General Counsel and Sec.	FTax Payment	−242 sh	$22.93	−$5,549.06	606
2019-06-14	AVEDRO INCRestricted Stock UnitsA Award	General Counsel and Sec.	AAward	+13.6K sh	—	—	13,565
2019-02-19	AVEDRO INCEmployee Stock Option (right to buy)A Award	General Counsel and Sec.	AAward	+44.5K sh	—	—	44,494
2016-01-21	ALBIREO PHARMA, INC.Employee Stock Option (right to buy)A Award	General Counsel	AAward	+500K sh	—	—	500,000
2014-12-19	ALBIREO PHARMA, INC.Stock Option (Right to Buy)A Award	General Counsel	AAward	+100K sh	—	—	100,000
2014-03-12	ALBIREO PHARMA, INC.M Exercise/Conversion	General Counsel	MExercise/Conversion	+4,801 sh	—	—	20,443
2014-03-12	ALBIREO PHARMA, INC.F Tax Payment	General Counsel	FTax Payment	−1,466 sh	—	—	18,977
2014-03-12	ALBIREO PHARMA, INC.Restricted Stock UnitM Exercise/Conversion	General Counsel	MExercise/Conversion	−4,801 sh	—	—	0
2013-12-23	ALBIREO PHARMA, INC.Stock Option (Right to Buy)A Award	General Counsel	AAward	+75K sh	—	—	75,000
2013-03-12	ALBIREO PHARMA, INC.M Exercise/Conversion	General Counsel	MExercise/Conversion	+4,799 sh	—	—	17,139
2013-03-12	ALBIREO PHARMA, INC.Restricted Stock UnitM Exercise/Conversion	General Counsel	MExercise/Conversion	−4,799 sh	—	—	4,801
2013-03-12	ALBIREO PHARMA, INC.F Tax Payment	General Counsel	FTax Payment	−1,497 sh	—	—	15,642
2012-12-21	ALBIREO PHARMA, INC.Stock Option (Right to Buy)A Award	General Counsel	AAward	−32K sh	—	—	32,000
2012-12-07	ALBIREO PHARMA, INC.S Sale	General Counsel	SSale	−12.3K sh	$2.80	−$34.3K	12,340
2012-11-02	ALBIREO PHARMA, INC.S Sale	General Counsel	SSale	−1,100 sh	$2.78	−$3,058	27,334
2012-11-01	ALBIREO PHARMA, INC.S Sale	General Counsel	SSale	−2,400 sh	$2.82	−$6,768	28,434
2012-09-30	ALBIREO PHARMA, INC.F Tax Payment	General Counsel	FTax Payment	−6,832 sh	$2.87	−$19.6K	24,596
2012-09-30	ALBIREO PHARMA, INC.M Exercise/Conversion	General Counsel	MExercise/Conversion	+18.6K sh	—	—	30,978
2012-09-30	ALBIREO PHARMA, INC.Restricted Stock UnitM Exercise/Conversion	General Counsel	MExercise/Conversion	+18.6K sh	—	—	0
2012-03-29	ALBIREO PHARMA, INC.Restricted Stock UnitsA Award	General Counsel	AAward	+74.6K sh	—	—	74,560
2012-03-13	ALBIREO PHARMA, INC.S Sale	General Counsel	SSale	−8,385 sh	$0.59	−$4,947.15	49,353
2012-03-12	ALBIREO PHARMA, INC.Restricted Stock UnitM Exercise/Conversion	General Counsel	MExercise/Conversion	−28K sh	—	—	0
2012-03-12	ALBIREO PHARMA, INC.M Exercise/Conversion	General Counsel	MExercise/Conversion	+28K sh	—	—	57,738
2011-11-23	ALBIREO PHARMA, INC.Stock Option (Right to Buy)A Award	General Counsel	AAward	+55K sh	—	—	55,000
2011-02-09	ALBIREO PHARMA, INC.S Sale	General Counsel	SSale	−3,658 sh	$2.04	−$7,462.32	29,788
2011-02-08	ALBIREO PHARMA, INC.M Exercise/Conversion	General Counsel	MExercise/Conversion	+10.5K sh	—	—	33,446
2010-12-14	ALBIREO PHARMA, INC.Stock Option (Right to Buy)A Award	General Counsel	AAward	+70K sh	—	—	70,000
2010-12-14	ALBIREO PHARMA, INC.Restricted Stock UnitsA Award	General Counsel	AAward	+35K sh	—	—	35,000
2010-05-09	ALBIREO PHARMA, INC.Employee Stock Option (right to buy)M Exercise/Conversion	General Counsel	MExercise/Conversion	+5,423 sh	—	—	5,423
2010-05-09	ALBIREO PHARMA, INC.M Exercise/Conversion	General Counsel	MExercise/Conversion	+5,423 sh	$1.94	+$10.5K	23,448
2009-12-15	ALBIREO PHARMA, INC.Restricted Stock UnitsA Award	General Counsel	AAward	+41.8K sh	—	—	41,800
2009-12-15	ALBIREO PHARMA, INC.Stock Option (Right to buy)A Award	General Counsel	AAward	+19.3K sh	—	—	19,338
2009-12-15	ALBIREO PHARMA, INC.Restricted Stock UnitM Exercise/Conversion	General Counsel	MExercise/Conversion	+10.5K sh	—	—	0

Recent filings

Accepted (ET)
Nov 254
Bavier Paul S0001209191-19-057926
SEC(opens sec.gov)
Sep 54
Bavier Paul S0001209191-19-048628
SEC(opens sec.gov)
Jun 184
Bavier Paul S0001209191-19-037838
SEC(opens sec.gov)
Feb 194
Bavier Paul S0001209191-19-011320
SEC(opens sec.gov)
Jan 254
Biodel Inc0001206774-16-004212
SEC(opens sec.gov)
Dec 234
Biodel Inc0001145443-14-001575
SEC(opens sec.gov)
Mar 144
Biodel Inc0001145443-14-000336
SEC(opens sec.gov)
Dec 234
Biodel Inc0001145443-13-002293
SEC(opens sec.gov)
Mar 144
Bavier Paul S0001466049-13-000019
SEC(opens sec.gov)

Companies

Address

C/O BIODEL INC. 100 SAW MILL ROAD

DANBURY, CT, 068810